buyer rumor

[Anonymous]

Purchaser will be:

One of these:
Astellas, Amgen or Bayer or most likely Janssen JnJ -

Provenge will make it once she has the backing and marketing power from one of these successful firms.

 

[Anonymous]

Purchaser will be:

One of these:
Astellas, Amgen or Bayer or most likely Janssen JnJ -

Provenge will make it once she has the backing and marketing power from one of these successful firms.

Your source?

 

[Anonymous]

Your source?

His rear end. Possibly also the little gnome who lives under his bed and promises he will eventually get all his money back from Dumbdeon.

LA LA LA LA LA....dreaming.....LA LA LA LA LA!

BAHAHAHAHAHAHAH!!!!

 

[Anonymous]

These 'happy happy joy joy' trolls are spilling over fr the yahoo DNDN board ( god what a train wreck of a message board)

 

[Anonymous]

J&J doesnt even LOOK at small companys' drugs worth less than $500M/yr revenue post launch, much less one thats FOUR YEARS in with negative returns. YOU'RE DELUSIONAL. None of those companys need this dog, with its high oveorhead and minimum return. Those companies you mention buy compounds from novel companies in Phase 1 or 2, and pre-launch phase 3. They could get a better ROI investing elsewhere.

I really cannot believe that you all continue to drink the Kool-Aid! Is that narcissist JE really THAT convincing of a liar, or are ya'll stupid?!